Use of procalcitonin (PCT) in risk stratification and prognosis of patients with a primary, non-infectious disease
US-11241395-B2 · Feb 8, 2022 · US
This page is not indexed by search engines while we improve data quality.
Patent family 39745280
This patent family groups 3 related publications across US. Members often share priority claims or equivalent filings in different countries.
| Field | Value |
|---|---|
| Family ID | 39745280 |
| Family type | — |
| Earliest priority | Aug 3, 2007 |
| First filing country | US |
| Member publications | 3 |
| Countries | US |
| Representative publication | US11241395B2 — Use of procalcitonin (PCT) in risk stratification and prognosis of patients with a primary, non-infectious disease |
Representative publication
Best representative member for this family based on priority and filing country.
US11241395B2 — Use of procalcitonin (PCT) in risk stratification and prognosis of patients with a primary, non-infectious disease (published Feb 8, 2022)
Member publications
Related publications in this family.